Clearside Biomedical Inc (NAS:CLSD)
$ 1.15 0 (0%) Market Cap: 85.96 Mil Enterprise Value: 57.46 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Q4 2022 Clearside Biomedical Inc Earnings Call Transcript

Mar 09, 2023 / 09:30PM GMT
Release Date Price: $1.19 (-3.25%)
Operator

Good day, and thank you for standing by. Welcome to the Clearside Biomedical fourth-quarter 2022 financial results and corporate update conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Jenny Kobin, Investor Relations. Please go ahead.

Jenny Kobin
Clearside Biomedical, Inc. - IR

Good afternoon, everyone, and thank you for joining us on the call today.

Before we begin, I would like to remind you that during today's call, we will be making certain forward-looking statements. Various remarks that we make during this call and about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our annual report on Form 10-K for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot